Title : Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study.

Pub. Date : 2022 Jan 11

PMID : 35016637






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib, which inhibits the VEGF pathway, has an immune-modulation function but lacks substantial clinical data. Sorafenib vascular endothelial growth factor A Homo sapiens